Peritoneal tuberculosis with elevated serum CA125 mimicking peritoneal carcinomatosis on F-18 FDG-PET/CT
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-07-01
著者
-
Wu Pei-shan
台湾
-
Wu Pei-shan
Department Of Nuclear Medicine Medical College National Cheng Kung University Medical Center
-
Lee Bi-fang
Department Of Nuclear Medicine Medical College National Cheng Kung University Medical Center
-
CHEN Chao-Jung
Department of Nuclear Medicine, Medical College, National Cheng Kung University Medical Center
-
YAO Wei-Jen
Department of Nuclear Medicine, Medical College, National Cheng Kung University Medical Center
-
CHOU Cheng-Yang
Department of Nuclear Medicine, Medical College, National Cheng Kung University Medical Center
-
CHIU Nan-Tsing
Department of Obstetrics and Gynecology, National Cheng Kung University Medical Center
-
Yao Wei-jen
Department Of Nuclear Medicine Medical College National Cheng Kung University Medical Center
-
Chiu Nan-tsing
Department Of Obstetrics And Gynecology National Cheng Kung University Medical Center
-
Chiu Nan-tsing
Department Of Nuclear Medicine National Cheng Kung University Hospital
-
Chen Chao-jung
Department Of Nuclear Medicine Medical College National Cheng Kung University Medical Center
-
Chou Cheng-yang
Department Of Nuclear Medicine Medical College National Cheng Kung University Medical Center
関連論文
- Peritoneal tuberculosis with elevated serum CA125 mimicking peritoneal carcinomatosis on F-18 FDG-PET/CT
- IS-20 Volume-activated taurine transport in human cervical cells with different tumor potential
- A computer-aided diagnosis of brain SPECT imaging using wavelets(International Forum on Medical Imaging in Asia 2009 (IFMIA 2009))
- IS-49 Loss of b type FGFR promote cell invasive ability- a possible role in cervical carcinogenesis(Group6 Oncology3,International Session)
- IS-11 GnRH agonist-induced DNA damage on uterine leiomyomas is indirectly through estrogen suppression
- IS-69 The Value of Preoperative Serum CA125 in Endometriosis Patient
- Novel method for preoperative prediction of Gonadotropin releasing hormone agonist (GnRH-a) treatment response in uterine leiomyoma by 3D power Doppler ultrasonography(Oncology 13)
- Serial follow up of uterine leiomyoma patient receiving GnRH-agonist with 3D power Doppler ultrasonography(Session15 Oncology7)
- Enhanced Polyadenosine Diphosphate-ribosylation of Smooth Muscle Cells in GnRH Agonist-Treated Uterine Leio-myoma(Session6 Oncology6)
- P-IS-17 Fibroblast growth factor receptor 1 (FGFR1) overexpression play a possible role in cervical carcinogenesis(Oncology 5,Group 92,International Session)
- P1-IS-49 Hysteroscopy Examination in Women with Breast Cancer Receiving Tamoxifen
- IS-33 The Expression of Circulating IGF System in Cervical Cancer and Ovarian Cancer : A Preliminary Result(Group5 Oncology5,International Session)
- IS-105 Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy(Group13 Oncology5,International Session)
- IS-72 Fas Ligand and Procaspase 3 Are Constitutively Expressed in Uterine Myometrium, Up-regulated in Leiomyoma and Down-regulated Following Gonadotropin Releasing Hormone Agonist Treatment
- Evidence of Human Papillomavirus Infection, Enhanced Phosphorylation of Retinoblastoma Protein and Decreased Apoptosis in Sarcomatoid Squamous Cell Carcinoma of Uterine Cervix(Oncology 8)
- Tc-99m sestamibi scanning in the preoperative localization of mediastinal parathyroid adenomas
- ISP-3-5 The role of human papillomavirus (HPV) types 16 E6/E7 oncoproteins in fibroblast growth factor (FGF) 2 and 4 induced cervical epithelial-mesenchymal transition (EMT) and carcinogenesis(Group 3 Oncology 3,IS Poster,International Session)